+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

U.S. Deep Brain Stimulation In Parkinson's Disease Market Size, Share & Trends Analysis Report by Product (Single-channel, Dual-channel), and Segment Forecasts, 2022-2030

  • PDF Icon

    Report

  • 110 Pages
  • July 2022
  • Region: United States
  • Grand View Research
  • ID: 5644972
The U.S. deep brain stimulation in Parkinson’s disease market size is expected to reach USD 849.49 million by 2030. It is expected to expand at a CAGR of 7.30% from 2022 to 2030. The rising prevalence of neurological conditions, such as Parkinson’s Disease (PD), increasing awareness, positive research outcomes, and growing investments in the development of transcranial stimulators are among the major factors driving the overall U.S DBS devices market.

DBS devices have been observed to be greatly effective in controlling the tremors associated with PD. They provide electrical stimulation to the basal ganglia, which results in suppressed neuronal activity that is generally spontaneous in patients suffering from PD. Low dopamine levels and other genetic factors are the main causes of PD. According to the Parkinson’s Foundation, about 1 million people are expected to be living with PD in the U.S. by 2020. Men are more susceptible to this disease than women.

Increasing investments for conducting R&D on PD have helped in raising awareness and boosting the development of new and innovative products and therapies for the treatment of this disease. For instance, the National Parkinson Foundation (NPF) provides funds to researchers and scientists with an aim to make advancements in this field. Extensive research activities for the inclusion and approval of deep brain stimulators in new application areas, such as full-body MRI scans and depression, are anticipated to boost the market growth over the forecast period. The DBS procedure price in the U.S. is around USD 96,000. It is expensive as compared with the cost of DBS procedures in countries such as the U.K. and Japan.

U.S. Deep Brain Stimulation In Parkinson’s Disease Market Report Highlights

  • By product, the dual-channel segment accounted for the largest revenue share of over 55.0% in 2021. Dual-channel DBS offers the best overall support, exhibiting greater effectiveness in reducing patient tremors and enhancing the quality of life
  • The single-channel product segment is estimated to register the highest CAGR over the forecast period. This is due to the cost of dual-channel DBS is high. Single-channel DBS offers patients suffering from progressed or complicated PD a chance to recover a part of their motion at a comparatively lower cost. Single-channel DBS is also easier to program and it offers greater room for operational flexibility
  • The industry is highly competitive. Market players are adopting various strategies, including partnerships, mergers and acquisitions, product innovations, and product launches to improve their position in the market
Frequently Asked Questions about the U.S. Deep Brain Stimulation In Parkinson’s Disease Market

What is the estimated value of the U.S. Deep Brain Stimulation In Parkinson’s Disease Market?

The U.S. Deep Brain Stimulation In Parkinson’s Disease Market was estimated to be valued at $483.6 Million in 2022.

What is the growth rate of the U.S. Deep Brain Stimulation In Parkinson’s Disease Market?

The growth rate of the U.S. Deep Brain Stimulation In Parkinson’s Disease Market is 7.3%, with an estimated value of $849.49 Million by 2030.

What is the forecasted size of the U.S. Deep Brain Stimulation In Parkinson’s Disease Market?

The U.S. Deep Brain Stimulation In Parkinson’s Disease Market is estimated to be worth $849.49 Million by 2030.

Who are the key companies in the U.S. Deep Brain Stimulation In Parkinson’s Disease Market?

Key companies in the U.S. Deep Brain Stimulation In Parkinson’s Disease Market include Boston Scientific Corporation, Abbott, Medtronic, Functional Neuromodulation, Ltd. and Aleva Neurotherapeutics SA.

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Product
1.1.2 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.2 Volume Price Analysis (Model 2)
1.6.2.1 Approach 2: Volume Price Analysis
1.7 List Of Secondary Sources
1.8 List Of Primary Sources
1.9 List Of Abbreviations
1.10 Objectives
1.10.1 Objective 1
1.10.2 Objective 2
1.10.3 Objective 3
1.10.4 Objective 4
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
Chapter 3 U.S. Deep Brain Stimulation In Parkinson’s Disease Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook
3.2 Penetration & Growth Prospect Mapping
3.3 User Perspective Analysis
3.3.1 Consumer Behavior Analysis
3.3.2 Market Influencer Analysis
3.4 List Of Key End Users
3.5 Market Dynamics
3.5.1 Market Driver Analysis
3.5.1.1 Increasing Prevalence Of Parkinson’s Disease
3.5.1.2 Technological Advancements In Deep Brain Stimulation (Dbs) Devices
3.5.1.3 Increasing Preference For Targeted Therapy Approach
3.5.1.4 Increasing Research On Dbs And Parkinson’s
3.5.2 Market Restraints Analysis
3.5.2.1 Complex Regulatory Framework
3.5.2.2 Risks Of Dbs Surgery
3.5.3 Market Challenges Analysis
3.5.3.1 Alternatives Of Dbs Systems
3.5.4 Market Opportunity Analysis
3.5.4.1 Increasing Clinical Studies On Dbs Assessments For Parkinson's Disease May Increase Demand In The Next Few Years
3.6 U.S. Deep Brain Stimulation In Parkinson’s Disease: Market Analysis Tools
3.6.1 Industry Analysis - Porter’s
3.6.2 Swot Analysis, By Pest
3.7 Impact Of Covid-19 On Market& Post Pandemic Insights
Chapter 4 U.S. Deep Brain Stimulation In Parkinson’s Disease Market: Segment Analysis, By Product, 2017 - 2030 (USD Million)
4.1 Definition And Scope
4.2 Product Market Share Analysis, 2021 & 2030
4.3 Segment Dashboard
4.4 U.S. Deep Brain Stimulation In Parkinson’s Disease Market, By Product, 2017 To 2030
4.5 Market Size & Forecasts And Trend Analyses, 2017 To 2030
4.5.1 Single-Channel
4.5.1.1 Single-Channel market, 2017 - 2030 (USD Million)
4.5.2 Dual-Channel
4.5.2.1 Dual-Channel market, 2017 - 2030 (USD Million)
Chapter 5 U.S. Deep Brain Stimulation In Parkinson’s Disease Market - Competitive Analysis
5.1 Recent Developments & Impact Analysis, By Key Market Participants
5.2 Company Categorization
5.2.1 Innovators
5.2.2 Market Leaders
5.3 Vendor Landscape
5.3.1 Key Company Market Share Analysis, 2021
5.3.2 Major Deals And Strategic Alliances
5.3.2.1 New Product Launch
5.3.2.2 Expansion
5.3.2.3 Acquistion
5.3.3 Market Entry Strategies
5.4 Company Profiles
5.4.1 BOSTON SCIENTIFIC CORPORATION
5.4.1.1 Company Overview
5.4.1.2 Financial Performance
5.4.1.3 Product Benchmarking
5.4.1.4 Strategic Initiatives
5.4.2 ABBOTT
5.4.2.1 Company Overview
5.4.2.2 Financial Performance
5.4.2.3 Product Benchmarking
5.4.2.4 Strategic Initiatives
5.4.3 MEDTRONIC
5.4.3.1 Company Overview
5.4.3.2 Financial Performance
5.4.3.3 Product Benchmarking
5.4.3.4 Strategic Initiatives
5.4.4 FUNCTIONAL NEUROMODULATION, LTD.
5.4.4.1 Company Overview
5.4.4.2 Product Benchmarking
5.4.4.3 Strategic Initiatives
5.4.5 NUVECTRA CORPORATION
5.4.5.1 Company Overview
5.4.5.2 Product benchmarking
5.4.5.3 Strategic Initiatives
5.4.6 ALEVA NEUROTHERAPEUTICS SA
5.4.6.1 Company Overview
5.4.6.2 Product benchmarking
5.4.6.3 Strategic Initiatives
List of Tables
Table 1. List of secondary sources
Table 2. List of abbreviation
Table 3. U.S. Deep Brain Stimulation in Parkinson’s Disease market, by product, 2017-2030 (USD Million)
List of Figures
Fig. 1 U.S.deep brain stimulation in Parkinson’s disease market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market outlook (2021)
Fig. 10 Segment outlook
Fig. 11 Strategy framework
Fig. 12 Penetration & growth prospect mapping
Fig. 13 Consumer behavior analysis
Fig. 14 Market driver relevance analysis (Current & future impact)
Fig. 15 Market restraint relevance analysis (Current & future impact)
Fig. 16 Porter’s five forces analysis
Fig. 17 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 18 U.S.deep brain stimulation in parkinson’s disease market: Product movement analysis
Fig. 19 Segment dashboard
Fig. 20 U.S.deep brain stimulation in parkinson’s disease market productoutlook: Key takeaways
Fig. 21 Single-channel market, 2017-2030 (USD Million)
Fig. 22 Dual-channel market, 2017-2030 (USD Million)
Fig. 23 Company market share analysis, 2021
Fig. 24 Market differentiators
Fig. 25 Country network map

Companies Mentioned

  • Boston Scientific Corporation
  • Abbott
  • Medtronic
  • Functional Neuromodulation, Ltd.
  • Nuvectra Corporation
  • Aleva Neurotherapeutics SA

Methodology

Loading
LOADING...